Kotak’s second special situations PE fund bankrolling big-ticket pharma acquisition

By TEAM VCC

  • 03 Jan 2024
Premium
Eshwar Karra, CEO, Kotak Special Situations Fund

Kotak Alternate Asset Managers (previously Kotak Investment Advisors), the alternative investment arm of Kotak Group, which hit a first close of its second special situation fund garnering $1.25 billion to invest via equity, debt and hybrid capital in companies across sectors, is coming to back a large pharmaceutical acquisition. Kotak Strategic Situations ......

This is a Premium article. Please subscribe or log in to read the full story!

Here's a selection of our recent premium content.

Already a member? Click here to log in.